Prateek Kumar Mittal
Direttore/Membro del Consiglio presso Medsource Ozone Biomedicals Pvt Ltd.
Profilo
Prateek Kumar Mittal has worked as a Director at Medsource Ozone Biomedicals Pvt Ltd since 2007.
Posizioni attive di Prateek Kumar Mittal
Società | Posizione | Inizio |
---|---|---|
Medsource Ozone Biomedicals Pvt Ltd.
Medsource Ozone Biomedicals Pvt Ltd. Medical SpecialtiesHealth Technology Medsource Ozone Biomedicals Pvt Ltd. was founded in 2003 and is based in Faridabad, IN. The company is one of the largest Indian In Vitro Diagnostics manufacturers and has been growing rapidly, establishing itself as one of the fastest-growing organizations in the South Asian region. The Indian company offers a comprehensive range of diagnostic solutions, including molecular diagnostic solutions with an emphasis on Real Time PCR Systems, Assays, Nucleic Acid Extraction solutions, and a host of supportive instruments, as well as training. The company's Electrolyte analyzers are designed for medium and high workload labs, hospitals, and ICUs and are FDA approved. | Direttore/Membro del Consiglio | 02/04/2007 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Medsource Ozone Biomedicals Pvt Ltd.
Medsource Ozone Biomedicals Pvt Ltd. Medical SpecialtiesHealth Technology Medsource Ozone Biomedicals Pvt Ltd. was founded in 2003 and is based in Faridabad, IN. The company is one of the largest Indian In Vitro Diagnostics manufacturers and has been growing rapidly, establishing itself as one of the fastest-growing organizations in the South Asian region. The Indian company offers a comprehensive range of diagnostic solutions, including molecular diagnostic solutions with an emphasis on Real Time PCR Systems, Assays, Nucleic Acid Extraction solutions, and a host of supportive instruments, as well as training. The company's Electrolyte analyzers are designed for medium and high workload labs, hospitals, and ICUs and are FDA approved. | Health Technology |
- Borsa valori
- Insiders
- Prateek Kumar Mittal